Correvio Pharma Corp. Comprehensive Income
Correvio Pharma Corp. reported Comprehensive Income of -$35.78 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2020-04-30
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|
| 2019-12-31 | -$35.78M 20-F · filed 2020-04-30 |
| 2018-12-31 | -$16.80M 20-F · filed 2020-04-30 |
| 2017-12-31 | -$29.02M 20-F · filed 2020-04-30 |
| 2016-12-31 | -$19.95M 20-F · filed 2018-04-30 |
| 2015-12-31 | -$24.91M 20-F · filed 2018-04-30 |
| 2014-12-31 | -$19.06M 40-F · filed 2016-03-29 |
| 2013-12-31 | $4.55M 40-F · filed 2015-03-27 |
| 2012-12-31 | -$18.32M 40-F/A · filed 2014-04-30 |
| 2011-12-31 | -$27.92M 20-F/A · filed 2013-04-18 |
| 2010-12-31 | $35.50M 20-F/A · filed 2013-04-18 |